Serum fibroblast growth factor 21 levels are increased in atrial fibrillation patients

Cytokine
Xinyuan HanChaofeng Sun

Abstract

Fibroblast growth factor 21 (FGF-21), a newly discovered adipokine, plays an important role in glucose and lipid metabolism and is associated with the development of metabolic disorders, such as obesity, and cardiovascular diseases. This study aimed to investigate the association of serum FGF-21 levels with the presence of atrial fibrillation (AF). Total 113 patients with AF and 60 healthy control subjects were enrolled. All AF cases were categorized into paroxysmal, persistent and permanent AF. Serum levels of FGF-21, high-sensitivity C-reactive protein (hs-CRP) and other routine biochemical parameters were measured. Serum FGF-21 levels were significantly higher in AF patients than in controls (250.12±78.48 vs. 144.15±56.31pg/mL, P<0.001), and hs-CRP levels were significantly higher in AF patients than in controls (2.36±1.10 vs. 1.24±0.82, P<0.05). In subgroup studies, patients with permanent AF had higher serum FGF-21 levels than those with persistent and paroxysmal AF. After the adjustment of the age, gender and body mass index, serum FGF-21 levels were positively correlated with left atrial diameter (LAD) (P<0.01). A multivariate logistic regression analysis showed that FGF-21, LAD and hs-CRP were correlated with AF (P<0.05...Continue Reading

References

Mar 16, 1994·JAMA : the Journal of the American Medical Association·E J BenjaminP A Wolf
Nov 25, 2004·JAMA : the Journal of the American Medical Association·Thomas J WangEmelia J Benjamin
May 20, 2005·The Journal of Clinical Investigation·Alexei KharitonenkovArmen B Shanafelt
Oct 28, 2006·Endocrinology·Alexei KharitonenkovGarret J Etgen
May 11, 2010·Gastroenterology·Jody DushayEleftheria Maratos-Flier
Jun 19, 2010·Circulation. Arrhythmia and Electrophysiology·George ThanassoulisEmelia J Benjamin
Aug 28, 2010·Journal of the American College of Cardiology·M Obadah Al ChekakieJoseph G Akar
Apr 23, 2011·Journal of the American College of Cardiology·Christopher X WongPrashanthan Sanders
Dec 15, 2012·Circulation·Alan S GoUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Jun 19, 2013·Nature Communications·A PlanavilaF Villarroya
Sep 12, 2013·Journal of Hepatology·Annika MutanenMikko P Pakarinen
Nov 26, 2013·Journal of cardiology·Kazım Serhan Özcanİzzet Erdinler

❮ Previous
Next ❯

Citations

Mar 20, 2016·Journal of Molecular Cell Biology·Xiaoyan HuiAimin Xu
Sep 6, 2015·The Journal of Endocrinology·Pongpan TanajakNipon Chattipakorn
Sep 18, 2015·Frontiers in Endocrinology·Anna PlanavilaFrancesc Villarroya
Oct 12, 2016·Bone·Christian Faul
Feb 2, 2018·Biomedical Reports·Juris LurinsVincenzo Baylon
Mar 25, 2019·Experimental and Therapeutic Medicine·Juris LurinsVincenzo Baylon
Aug 2, 2015·American Journal of Physiology. Heart and Circulatory Physiology·Eleni M DomouzoglouEleftheria Maratos-Flier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Asprosin

Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.